Bojungikki-tang extracts on immune function after concurrent chemoradiation therapy in patients with cervical cancer : a pilot study

Comprehensive and Integrative Medical Institute0 个研究点目标入组 20 人开始时间: 待定最近更新: 2019年3月11日

试验速览

暂无简介。

•1. Patients with cervical cancer who have received chemoradiation before 1-6 month.
•2. ECOG performance 0-2
•3. Age: 30-70
•4. No disability of cognitive function
•5. Patients who can be possible to follow up during this study
•6. Patients who have signed an approved informed consent

•1. Patietns who have a history of hypersensitivity after taking Bojungikki-tang granules.
•2. Patients who have an autoimmune diseases such as rheumatoid arthritis, Hashimoto's thyroiditis , Bechet's disease , etc.
•3. Diabetes
•4. Patients who have significant psychiatric history or currently suffering from such diseases.
•5. Severe liver or kidney failure at liver and kidney function test.
•6. Patients who have alcohol or drug abuse history
•7. Patients who did not signe an approved informed consent.
•8. Patients who are not suitable for this study

发起方

Comprehensive and Integrative Medical Institute